SCHEMBL23970612

SCHEMBL23970612

O=C(OCc1ccccc1)N1CCCCC2(CNC2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.50
CYP2D6 P10635 5/20 0.50
CYP1A2 P05177 5/20 0.50
CYP2C19 P33261 3/20 0.50
CYP2C9 P11712 3/20 0.50
ENPP2 Q13822 2/20 0.49
ATXN2 Q99700 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ACACB O00763 1/20 0.46
USP2 O75604 4/20 0.45
MAPK1 P28482 1/20 0.45
HTR2C P28335 1/20 0.44
TSHR P16473 4/20 0.43
ALDH1A1 P00352 2/20 0.43
GRIN2B Q13224 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL614422 0.91 ENPP2 (0.57) CYP3A4CYP2D6CYP1A2CYP2C19CYP2C9
Hydrochloric Acid SCHEMBL28379028 0.90 ATXN2 (0.56) CYP3A4CYP2D6CYP1A2CYP2C19CYP2C9
SCHEMBL16144658 0.88 CYP3A4 (0.50) CYP3A4CYP2D6CYP1A2CYP2C19CYP2C9
Hydrochloric Acid SCHEMBL28384503 0.87 CYP3A4 (0.49) CYP3A4CYP2D6CYP1A2CYP2C19CYP2C9
SCHEMBL15268978 0.86 CYP3A4 (0.55) CYP3A4CYP2D6CYP1A2CYP2C19CYP2C9
SCHEMBL10153538 0.86 MEN1 (0.54) CYP2C19ENPP2ATXN2MEN1KMT2A
SCHEMBL2727354 0.85 CYP3A4 (0.58) CYP3A4CYP2D6CYP1A2CYP2C19CYP2C9
Hydrochloric Acid SCHEMBL16678836 0.84 CYP3A4 (0.57) CYP3A4CYP2D6CYP1A2CYP2C19CYP2C9
SCHEMBL12683551 0.83 ENPP2 (0.56) CYP3A4CYP2D6CYP1A2CYP2C19CYP2C9
Oxalic Acid SCHEMBL25382875 0.83 MEN1 (0.51) CYP2C19ENPP2ATXN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11976083-B2 Inhibitors of peptidylarginine deiminases GILEAD SCIENCES, INC. (US) 2024-05-07 US disclosed
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
EP-4143189-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2023-03-08 EP disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
CN-115551862-A Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2022-12-30 CN disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11976083-B2 Inhibitors of peptidylarginine deiminases PADI4, PADI2, PADI1 CYP3A4 3493/4885CYP2D6 3315/4885CYP1A2 3908/4885
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 CYP3A4 3493/4885CYP2D6 3315/4885CYP1A2 3908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.